Track Tetratherix Ltd. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Tetratherix Ltd. TTX.AX · Stock Open Tetratherix Ltd. in new tab

5.85 AUD
Add to portfolio
EPS
-0.40
P/B
12.23
ROE
-150.03
Target Price
6.12 AUD
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 27, 2026
EPS-0.40
Book Value0.48
Price to Book12.23
Debt/Equity45.98
% Insiders118.449%
Growth
Revenue Growth2.06%
Estimates
Forward P/E-44.03
Forward EPS-0.15
Target Mean Price6.12

DCF Valuation

Tweak assumptions to recompute fair value for Tetratherix Ltd. (TTX.AX)
Currency: AUD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Tetratherix Ltd. Logo Tetratherix Ltd. Analysis (TTX.AX)

Australia Healthcare Official Website Stock

Is Tetratherix Ltd. a good investment? Tetratherix Ltd. (TTX.AX) is currently trading at 5.85 AUD. Market analysts have a consensus price target of 6.12 AUD. This suggests a potential upside from current levels.

Earnings Schedule: Tetratherix Ltd. is expected to release its next earnings report on Aug. 27, 2026. The market consensus estimate for Forward EPS is -0.15.

Investor FAQ

Does Tetratherix Ltd. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Tetratherix Ltd.?

Tetratherix Ltd. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 27, 2026. The company currently has a trailing EPS of -0.40.

Company Profile

Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.

Exchange Ticker
ASX TTX.AX
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion